Free PMH-C practice questions

PMH-C exam practice questions: Psychopharmacology and other somatic interventions

Psychopharmacology on the PMH-C exam is about education and risk-benefit conversations for every track, not prescribing. It also tests how to read the studies behind the headlines.

7% of the exam: 7 of the 100 scored questions · about 9 of 125 in a full-length mock · 53 questions in the bank

Original questions, not recalled exam items. These come from the PMH-C Exam QBank question bank. They are drafted by AI from cited clinical sources, checked by two independent AI reviews and mapped to PSI's 2024 content outline; clinician review is still to come. They are for exam preparation, not clinical advice. PMH-C Exam QBank is independent and not affiliated with or endorsed by Postpartum Support International (PSI) or Pearson VUE. Be wary of anything sold as "actual exam questions."

What this domain covers

In our words, PSI's 2024 Detailed Content Outline lists these areas for Psychopharmacology and Other Somatic Interventions:

Summarized from PSI's 2024 Detailed Content Outline (PDF), checked November 14, 2026. Read the outline itself for the full list of objectives.

Areas to know well

How to study it

Learn the study-design vocabulary first: it is the part of this domain that every track can master. Then practice explaining a risk in plain words, with the uncertainty stated honestly.

Free practice questions: psychopharmacology

Three questions from the bank, each with the answer, an explanation of every option and its source. Commit to an answer before you open each explanation.

Question 1 · Interpreting relative infant dose

A lactation consultant reads in LactMed that an exclusively breastfed infant would receive about 1% of the mother's weight-adjusted dose of her antidepressant. The mother asks what this number means. Which explanation is most accurate?

  1. A. The milk concentration is about 1% of her blood concentration, which is the milk-to-plasma ratio.
  2. B. The infant's blood level is about 1% of her blood level, which is the infant serum level ratio.
  3. C. The infant takes in about 1% of her total daily mg dose, without adjusting for weight.
  4. D. The infant's mg/kg intake is about 1% of her mg/kg dose, which is the relative infant dose.
Show answer and explanation

Answer: D. The infant's mg/kg intake is about 1% of her mg/kg dose, which is the relative infant dose.

A (incorrect): The milk-to-plasma ratio compares drug concentrations in milk and maternal plasma. It is a real measure used in estimating intake, but the stem's figure is a percentage of the mother's weight-adjusted dose, not a concentration ratio.

B (incorrect): Infant serum levels are reported separately in LactMed when they have been measured. The stem's figure is an estimate of dose taken in from milk relative to her weight-adjusted dose, not a measured infant blood level.

C (incorrect): The stem specifies a weight-adjusted dose, so the comparison is mg/kg to mg/kg. An unadjusted percentage of the total dose would understate exposure for a small infant.

D (correct): LactMed's relative infant dose is the weight-adjusted percentage of the maternal dosage that a fully breastfed infant would take in, which is the measure described in the stem. For most drugs, a value of 10% or less is considered relatively safe, so 1% is low.

Source: Drugs and Lactation Database (LactMed). Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Drugs and Lactation Database (LactMed) - Record Format. NCBI Bookshelf NBK547442. Drug Levels (relative infant dose definition and interpretation). https://www.ncbi.nlm.nih.gov/books/NBK547442/

Question 2 · Hypnotic complex sleep behavior

A client at 4 months postpartum was prescribed zolpidem for insomnia. Her partner tells the family support worker that last night she got up, cooked food on the stove and has no memory of it this morning. Which response is most appropriate?

  1. A. She should stop taking zolpidem now, and her prescriber should be told about this episode today.
  2. B. She should taper zolpidem over a week, and her prescriber should be told about this episode today.
  3. C. She should take a lower zolpidem dose, and her prescriber should be told about this episode today.
  4. D. She should take zolpidem on nights her partner is home, and her prescriber should hear today.
Show answer and explanation

Answer: A. She should stop taking zolpidem now, and her prescriber should be told about this episode today.

A (correct): Cooking while not fully awake with no memory of it is a complex sleep behavior, the subject of zolpidem's boxed warning. The label directs that zolpidem be discontinued immediately after a complex sleep behavior, so she should stop and her prescriber should hear about it today.

B (incorrect): Gradual tapering is often sensible when stopping a hypnotic after regular use, but after a complex sleep behavior the label directs immediate discontinuation. Continuing doses during a taper keeps her exposed to the same risk.

C (incorrect): Lower doses reduce next-morning impairment, and prompt prescriber contact is right, but a complex sleep behavior is a labeled reason to stop zolpidem, not to lower the dose.

D (incorrect): Supervision may reduce harm from some events, but it does not remove the risk, and complex sleep behaviors can cause serious injury. The label calls for discontinuation after one occurs.

Source: PD-Rx Pharmaceuticals, Inc. Zolpidem tartrate tablets, film coated: full prescribing information. DailyMed set ID 38c838a4-9943-445a-8e80-e823d56eeaa5. National Library of Medicine; 2026. Boxed Warning: Complex Sleep Behaviors; Section 2.1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38c838a4-9943-445a-8e80-e823d56eeaa5

Question 3 · Purpose of sibling comparison designs

A peer support facilitator is preparing a handout about how researchers study antidepressant use in pregnancy. A Swedish cohort study compared children exposed to an antidepressant in the first trimester with their own brothers and sisters from pregnancies in which the mother took no antidepressant. What is the main purpose of this comparison?

  1. A. To test whether a similar link appears when the father, not the mother, took the antidepressant
  2. B. To test whether a similar link appears when the mother took the antidepressant only before pregnancy
  3. C. To compare exposed with unexposed pregnancies among other people who had the same diagnosis
  4. D. To hold constant the genetic and family factors that one mother's pregnancies have in common
Show answer and explanation

Answer: D. To hold constant the genetic and family factors that one mother's pregnancies have in common

A (incorrect): Comparing with fathers' use is a paternal negative control: a father's medication cannot reach the fetus, so a similar association with paternal use points to shared family factors. The analysis in the stem compared siblings, which is a different design.

B (incorrect): Comparing with use only before pregnancy is a timing control that asks whether a link reflects the people who take the drug rather than fetal exposure. It is a separate analysis from comparing siblings.

C (incorrect): Restricting to people with the same diagnosis addresses confounding by indication, but it compares different families. It does not hold constant the genes and home environment that siblings share.

D (correct): Siblings have the same mother, share part of their genes and usually much of their family environment, so stable maternal and family traits are held constant. An association that disappears in the sibling analysis points toward family-level confounding rather than a drug effect. In this Swedish study, analyses of maternal use before pregnancy and of paternal use gave results consistent with the sibling comparisons.

Source: Sujan AC, Rickert ME, Oberg AS, Quinn PD, Hernandez-Diaz S, Almqvist C, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA. 2017;317(15):1553-1562. doi:10.1001/jama.2017.3413. PMID: 28418479. Abstract, Design, Setting, and Participants. https://pubmed.ncbi.nlm.nih.gov/28418479/

The full bank has 669 questions

Practice all 53 psychopharmacology questions, and the other 11 domains

Get 419 practice questions across all 12 domains, two timed mock exams weighted like the real exam (125 questions in 3 hours, or a 60-question half-length version), and an explanation with its source for every option, backed by a pass-or-refund guarantee.

See the full question bank

One-time purchase · No subscription · Pass-or-refund guarantee

Original questions drafted by AI from cited sources and checked by two independent AI reviews; clinician review is still to come.

Other PMH-C exam domains

PMH-C exam 2027: dates, cost, format, eligibility · PMH-C exam prep: an eight-week study plan